Drug Metabolism May Be Suppressed in Patients With Inflammatory Conditions
Suppressed drug metabolism was identified in patients with various inflammatory conditions.
News
LATEST NEWS
Predictors of Smell Recovery Identified in COVID-19 Patients
About four of every five patients with COVID-19-related olfactory loss report smell recovery within six months.
California Expands Access to Free Menstrual Products in Schools
Free menstrual pads and tampons must be provided in restrooms at all California public schools and colleges starting in the 2022-2023 academic year.
Merck Asks FDA to Approve First COVID-19 Antiviral Pill
Merck & Co. announced that it had submitted an application with the FDA for emergency use approval of the first antiviral pill targeted to COVID-19.
The Functional Pain Scale is a Reliable Measure of Pain
The Functional Pain Scale is a reliable and consistent patient-reported measure of pain.
Zimhi Approved for Emergency Treatment of Opioid Overdose
Zimhi is intended for immediate administration as emergency therapy in settings where opioids may be present.
Ciclesonide May Be Promising Outpatient Therapy for Early COVID-19
Clinical trial results indicate that ciclesonide inhalation may be an effective early antiviral therapy for mild to moderate COVID-19.
Health Care Workers Show Greatest COVID-19 Stress
Health care workers experienced higher levels of stress than other occupations in the first wave of the COVID-19 pandemic.
Hospital Discharge Tied to Higher Risk for Opioid-Related Deaths
Discharge from the hospital is associated with an acute increase in the risk for opioid-related deaths in England.
Gut Dysbiosis May Affect Distal Neuropathic Pain Development in HIV
Gut dysbiosis may contribute to the development of distal neuropathic pain in people living with HIV.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Loading... 
Loading...